bladder carcinoma

Open Access
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
MICHELE DIONESE, DAVIDE BIMBATTI, FRANCESCO PIERANTONI, ELEONORA LAI, ELISA ERBETTA, NICOLÒ CAVASIN, SALIM JUBRAN, UMBERTO BASSO and MARCO MARUZZO

Anticancer Research October 2024, 44 (10) 4379-4386; DOI: https://doi.org/10.21873/anticanres.17267
You have access
Expression of γ-Synuclein in Bladder Carcinoma: A Possible Marker for Prognosis
ZHIGANG CHEN, ZHIGANG JI, QINGHAI WANG, BINGBING SHI, CHENGCHAO SHOU, CAIYUN LIU, HUA FAN, HANZHONG LI, KRISTOFFER T. DAVIDSON, MARK R. WAKEFIELD, TYLER W. BALL and YUJIANG FANG

Anticancer Research March 2016, 36 (3) 951-956;
You have access
AG11, A Novel Dichloroflavanone Derivative with Anti-mitotic Activity Towards Human Bladder Cancer Cells
AURELIE JUHEM, AHCENE BOUMENDJEL, BASTIEN TOUQUET, AMANDINE GUILLOT, ANDREÏ POPOV, XAVIER RONOT and VERONIQUE MARTEL-FRACHET

Anticancer Research October 2013, 33 (10) 4445-4452;
You have access
Stable Knockdown of hCGβ mRNA Expression in Bladder Cancer Cells Results in Significant Growth Inhibition
BEATA BURCZYNSKA, MATTHEW J. BOOTH, RAY K. ILES, ANKITA SHAH, ASHREF SHILED and STEPHEN A. BUTLER

Anticancer Research September 2013, 33 (9) 3611-3614;

Main menu